Video Latest - ecancer

What will we expect from novel therapies for oesophageal and gastric malignancies?

Prof Ramon De Mello - University of Algarve, Faro, Portugal

2 Jun 2018

Diagnostics and classification of brain tumours

Dr David Louis - Massachusetts General Hospital, Boston, USA

11 May 2018

Identifying drivers of resistance in childhood brain tumours

Dr Pratiti Bandopadhayay - Dana-Farber Cancer Institute, Boston, USA

11 May 2018

Funding collaborations and discovery in treating brain cancers

Dr Iain Foulkes - Executive Director, Research & Innovation / CEO of Cancer Research Technology

11 May 2018

Incorporating biomarkers into clinical trial design

Dr Amar Gajjar - St. Jude Children's Research Hospital, Memphis, USA

11 May 2018

The 2018 Myeloma Knowledge Exchange

Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria

4 May 2018

Increasing diversity through the NCI SBIR development centre

Dr Christie Canaria - National Cancer Institute, Rockville, USA

25 Apr 2018

The importance of online patient groups and 'The ROS1ders'

Janet Freeman-Daily - The ROS1ders

25 Apr 2018

Clinical development and economic prospects of CAR T cell immunotherapies

Dr Bob Velamehr - Fate Therapeutics, La Jolla, USA

25 Apr 2018

How the SBIR development centre funds cancer initiatives

Michael Weingarten - National Cancer Institute, Rockville, USA

25 Apr 2018

Supporting technological initiatives in low and middle income countries

Dr Paul Pearlman - National Cancer Institute, Rockville, USA

25 Apr 2018

ecancer e-learning

12 Apr 2018

Video